159 related articles for article (PubMed ID: 9716444)
21. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
Yang DC; Jiang X; Elliott RL; Head JF
Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
[TBL] [Abstract][Full Text] [Related]
22. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer.
Xi Y; Nakajima G; Schmitz JC; Chu E; Ju J
BMC Genomics; 2006 Apr; 7():68. PubMed ID: 16584549
[TBL] [Abstract][Full Text] [Related]
23. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
[TBL] [Abstract][Full Text] [Related]
24. High-level expression of human thymidylate synthase.
Pedersen-Lane J; Maley GF; Chu E; Maley F
Protein Expr Purif; 1997 Jul; 10(2):256-62. PubMed ID: 9226722
[TBL] [Abstract][Full Text] [Related]
25. Aminoglycoside antibiotics are able to specifically bind the 5'-untranslated region of thymidylate synthase messenger RNA.
Tok JB; Cho J; Rando RR
Biochemistry; 1999 Jan; 38(1):199-206. PubMed ID: 9890899
[TBL] [Abstract][Full Text] [Related]
26. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.
Deere J; Iversen P; Geller BL
Antimicrob Agents Chemother; 2005 Jan; 49(1):249-55. PubMed ID: 15616302
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of p21/WAF1 expression by thymidylate synthase.
Kastanos EK; Zajac-Kaye M; Dennis PA; Allegra CJ
Biochem Biophys Res Commun; 2001 Jul; 285(2):195-200. PubMed ID: 11444825
[TBL] [Abstract][Full Text] [Related]
28. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L
Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882
[TBL] [Abstract][Full Text] [Related]
29. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
Nivens MC; Felder T; Galloway AH; Pena MM; Pouliot JJ; Spencer HT
Cancer Chemother Pharmacol; 2004 Feb; 53(2):107-15. PubMed ID: 14605862
[TBL] [Abstract][Full Text] [Related]
30. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
31. Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells.
Ferguson PJ; DeMoor JM; Vincent MD; Koropatnick J
Br J Pharmacol; 2001 Dec; 134(7):1437-46. PubMed ID: 11724749
[TBL] [Abstract][Full Text] [Related]
32. Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.
Ishida Y; Kawakami K; Tanaka Y; Kanehira E; Omura K; Watanabe G
Anticancer Res; 2002; 22(5):2805-9. PubMed ID: 12530000
[TBL] [Abstract][Full Text] [Related]
33. Complex transcriptional initiation pattern of the thymidylate synthase promoter in mouse tissues.
Lee Y; Shen G; Johnson LF
Arch Biochem Biophys; 1999 Dec; 372(2):389-92. PubMed ID: 10600180
[TBL] [Abstract][Full Text] [Related]
34. Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
Pandyra AA; Berg R; Vincent M; Koropatnick J
J Pharmacol Exp Ther; 2007 Jul; 322(1):123-32. PubMed ID: 17452420
[TBL] [Abstract][Full Text] [Related]
35. Hybridization arrest of cell-free translation of the malarial dihydrofolate reductase/thymidylate synthase mRNA by anti-sense oligodeoxyribonucleotides.
Sartorius C; Franklin RM
Nucleic Acids Res; 1991 Apr; 19(7):1613-8. PubMed ID: 2027768
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of transforming growth factor beta (TGFbeta1) expression and extracellular matrix secretion in human peritoneal mesothelial cells by pcDU6 vector-mediated TGFbeta1 shRNA and by pcDNA3.1(-)-mediated antisense TGFbeta1 RNA.
Liu F; Liu H; Peng Y; Yuan F; Liu Y; Duan S
Adv Perit Dial; 2005; 21():41-52. PubMed ID: 16686283
[TBL] [Abstract][Full Text] [Related]
37. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer.
Kasahara M; Takahashi Y; Nagata T; Asai S; Eguchi T; Ishii Y; Fujii M; Ishikawa K
Clin Cancer Res; 2000 Jul; 6(7):2707-11. PubMed ID: 10914714
[TBL] [Abstract][Full Text] [Related]
38. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
Jen KY; Gewirtz AM
Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
[TBL] [Abstract][Full Text] [Related]
39. Influence of capping and polyadenylation on mRNA expression and on antisense RNA mediated inhibition of gene expression.
Bechler K
Biochem Biophys Res Commun; 1997 Dec; 241(1):193-9. PubMed ID: 9405256
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]